9
Participants
Start Date
March 10, 2025
Primary Completion Date
February 20, 2026
Study Completion Date
December 26, 2027
BL0175
"BL0175 is a nano-medicine for cancer therapy. Nano-medicine means the tiny size of this study drug allows it to enter and concentrate into the tumor tissue. This is a new way of delivering an active drug (an estrogen receptor down regulator) for the treatment of tumor directly into tumor tissue."
RECRUITING
The First Hospital of Jilin University, Changchun
RECRUITING
Jinan Central Hospital, Jinan
Shanghai Best-Link Bioscience, LLC
INDUSTRY